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Concurrent rheumatoid arthritis and ankylosing 
spondylitis in one patient: the importance of 
new classifi cation criteria
Valderilio Feijó Azevedo1, Pedro Grachinski Buiar2
ABSTRACT
We report the case of concomitant ankylosing spondylitis and rheumatoid arthritis in a 65-year-old Caucasian male, 
who had symmetric polyarthritis with erosion of the metacarpophalangeal joint on conventional X-ray, inÀ ammatory 
low back pain with HLA-B27 positivity, and sacroiliitis. Laboratory analysis showed high levels of rheumatoid factor 
and anti-cyclic citrullinated peptide antibody (anti-CCP). Clinical features of previously reported cases were compared 
with those of our case. This is the ¿ rst case report on the coexistence of both diseases in the same patient, for whom anti-
CCP testing and the latest versions of axial ASAS criteria and ACR/EULAR criteria for the classi¿ cation of ankylosing 
spondylitis and rheumatoid arthritis, respectively, were used. 
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INTRODUCTION
Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) 
are chronic and progressive inÀ ammatory joint diseases that 
lead to joint damage and functional disability. In the past, 
AS was included in the RA spectrum and considered an 
axial variant of that. Since the 1950s, when the rheumatoid 
factor (RF) ‘appeared’, several different characteristics have 
been established to  differentiate those two rheumatologic 
disorders.1 Currently, each disease has its own well-de¿ ned 
diagnostic criteria. To such criteria, laboratory tests that 
identify antibodies and genes related to each disease, such as 
HLA-DR4 and HLA-B27, have been added. The anti-cyclic 
citrullinated peptide antibody (anti-CCP), currently used 
in the diagnosis of RA, has been the main focus of studies. 
Coexistence of RA and AS in the same patient is rare. Of the 
almost 50 cases described in the literature, a large number 
was reported more than 30 years ago, when speci¿ c labora-
tory tests were not available and the classi¿ cation criteria of 
both diseases were still largely debated. 
Many of those cases have been published as an extremely 
rare occurrence.2–4 In 1979, Major et al.2 reported 2 cases and 
commented on 21 others that had already been described in 
the English literature. In 1995, Toussirot et al.3 reported 3 
more cases and, reviewing the literature, found 44 previous 
cases. Since then, some more cases have been added, but the 
frequency of their report has decreased. In this article, we report 
the diagnosis of RA and AS in the same patient by using the 
ASsessment in Ankylosing Spondylitis (ASAS) group criteria 
for axial AS and the 2010 American College of Rheumatology/
European League Against Rheumatism (ACR/EULAR) crite-
ria along with anti-CCP testing for RA, which had not been 
performed in previous reports. Among the updated 2010 ACR/
EULAR criteria for RA, anti-CCP testing is worthy of note.5
CASE REPORT
The patient is a 65-year-old retired Caucasian male, long-time 
smoker and alcohol drinker, who was admitted due to polyar-
thralgia and weight loss (5 kg in approximately 1.5 month). 
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The patient reported low back and chest pain initiated approxi-
mately 1 year and 4 months before, which worsened at night 
and improved with physical activities, in addition to morning 
stiffness for approximately 40 minutes. He also complained 
of mild pain in his right tarsal joints and right knee, with no 
edema associated, and that, two months before admission, 
moderate pain initiated on mobilization of both elbows and 
metacarpophalangeal joints. He denied cough, night sweating 
and fever in the period. He also denied any similar previous 
history, urethritis, intestinal symptoms or even a previous 
diagnosis of rheumatic disorder. 
On physical examination, the patient was lucid and ori-
ented, with a facial expression of pain. His general state of 
health was good. His cervical spine was stiff and had bilateral 
limited mobility (< 45o). On palpation, his lumbar spine was 
painful at the L3-L5 level. Schöber’s tests, 10.0–11.6 cm; chest 
expandability, 2.1 cm; occipital-wall distance, 0 cm. His shoul-
ders and elbows evidenced, bilaterally, an increase in volume 
and temperature, and limited mobility (extension). Both hands 
showed Bouchard and Herberden nodules, and atrophy of the 
interosseous muscles. His knees were tender on palpation and 
clicked with motion. A small erythematous cutaneous lesion 
was identi¿ ed on the right knee, and was biopsied. No nodules 
were identi¿ ed. His blood pressure was 145x95 mm Hg, heart 
rate, 125 bpm, and respiratory rate, 20 rpm. His laboratory 
exams were as follows: erythrocyte sedimentation rate (ESR), 
111 mm/1h (up to 32.5 mm/1h); C-reactive protein (CRP), 
9 mg/dL (normal: 0.5 mg/dL); hematocrit, 36.2%; hemoglobin, 
11 g/dL; platelets, 429,000/mm3; leukocytes, 8120/mm3; RF, 
633 IU/mL. Radiographies of the sacroiliac and lumbar spinal 
joints evidenced sclerosis of the sacroiliac joints bilaterally 
without erosions (grade 2), more evident on the right side, and 
syndesmophytes on L4 and L5 (Figure 1a). The biopsy of the 
skin lesion of the right knee revealed super¿ cial perivascular 
chronic dermatitis, whose cause was not established, and not 
compatible with a psoriatic lesion. The exam was positive for 
HLA-B27. The patient was discharged following improvement 
after treatment with non-steroidal anti-inÀ ammatory drugs 
and sulfasalazine. His scores were as follows: BASFI = 6.5; 
BASDAI = 5.8; DAS-28 = 5.5.
The patient returned only after one year, reporting general 
improvement of the pain in his knees, shoulders and hands. He 
also reported mild pain on the left second and third ¿ ngers two 
months before. The physical examination then showed the fol-
lowing: edema of the right second metacarpophalangeal joint, 
left second and third metacarpophalangeal joints and left el-
bow; pain on bone palpation of all metacarpophalangeal joints; 
edema and pain on palpation of the left acromioclavicular 
joint; increased volume and pain of the left second, third and 
fourth metacarpophalangeal joints; and increased volume of 
the right second metatarsophalangeal joint. His laboratory 
¿ ndings were as follows: RF, 526 IU/mL; CRP, 4.64 mg/
dL; and ESR, 42 mm/1h. Radiography of his hands showed 
mild erosion of the right ¿ rst metacarpophalangeal joint, 
reduced joint space, and reduced juxta-articular bone density 
(Figure 1b ). The anti-CCP antibody titer was 525 (strong 
positivity > 60 Au). 
His 2010 ACR/EULAR score for RA was 8 (positive 
diagnosis). At the time, the patient was diagnosed with RA 
and AS, and the following drugs were prescribed: diclofenac 
(150 mg/day), prednisone (7.5 mg/day) and methotrexate 
(15 mg/week). Currently, the patient is being followed up 
on the outpatient clinic, with indication for treatment with a 
biologic agent (tumor necrosis factor inhibitor – anti-TNF). 
Figure 1
(A) Discrete erosion of the right ¿ rst metacarpophalangeal 
joint, reduced joint space, and decreased juxta-articular 
bone density. (B) Sclerosis of the sacroiliac joints bilaterally 
without erosions, more evident at the right side (grade 2), and 
syndesmophytes on L4 and L5. 
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DISCUSSION
Physiopathological, clinical and diagnostic differences be-
tween RA and AS have been well established. Rheumatoid ar-
thritis has prevalence of 1%–2% in the Caucasian population 
and is associated with the HLA-DR4 or DR1 genes (present 
in 60% of the patients).6 Its incidence peaks between the ages 
of 40 and 70 years, and RA is more prevalent in the female 
sex. Ankylosing spondylitis has prevalence of 0.2%–0.9% in 
the Caucasian population and is associated with the HLA-B27 
gene (present in approximately 95% of individuals with 
AS).7–9 Although our patient can be considered elderly, AS 
has an incidence peak between the ages of 20 and 45 years, 
showing male predominance.7 Rarely it occurs at more ad-
vanced ages. Although HLA-B27 has gained importance, in 
the genetic group with that histocompatibility antigen, the 
risk of developing AS is lower than 50%.9 
Rheumatoid arthritis usually manifests as symmetric 
polyarthritis that affects the small joints of the hands and feet, 
metacarpophalangeal, metatarsophalangeal, and proximal 
interphalangeal joints, rarely affecting entheses. It can af-
fect the cervical spine. However, AS occurs most often as an 
inÀ ammatory low back pain, which can be accompanied by 
enthesitis and asymmetrical oligoarthritis, preferably of axial 
and large joints, such as shoulders, hips and knees, its major 
characteristic being the involvement of the sacroiliac joints, 
and, at advanced stages, vertebral ankylosis at all levels.10
The most common extra-articular manifestations of RA 
are subcutaneous nodules, keratoconjunctivitis sicca, pleu-
ral and pericardial involvement, and vasculitis. Ankylosing 
spondylitis, however, can manifest as psoriasis, acute anterior 
uveitis, ¿ brosis of the pulmonary apex, inÀ ammatory bowel 
disease, heart valve problems, and heart electrical conduction 
disorders.11 Aggravation of gastrointestinal lesions and peptic 
ulcers with the use of non-steroidal anti-inÀ ammatory drugs 
and disease-modifying antirheumatic drugs (DMARDs) is 
common in both diseases.12 
In RA, there is evidence of bone resorption in the form of 
erosions. In AS, there is bone erosion associated with bone 
neoformation in the form of syndesmophytes. It is worth not-
ing that ¿ nding bilateral sacroiliitis is highly suggestive of AS. 
In our patient’s case, the radiologic ¿ ndings of juxta-articular 
osteopenia, erosion of the right ¿ rst metacarpophalangeal joint, 
and bilateral sacroiliitis with syndesmophytes on L4 and L5 
supported both diagnoses.
The CRP and ESR levels are parameters frequently used 
to show inÀ ammatory activity, being also criteria for the 
clinical activity monitoring of both diseases, being elevated 
in most patients with active RA, but also in 50%–60% of the 
patients with active AS.13 The RF is almost always present in 
patients with RA (around 70%–90%), and their levels can be 
directly correlated with disease severity. Nevertheless, the RF 
is not speci¿ c, being also present in a series of other clinical 
conditions. Although 10%–15% of the patients with spondy-
loarthritis might have RF, their titers are usually lower,6 unlike 
this case, whose titers were elevated. A extremely speci¿ c test 
developed at the end of the 1970s is anti-CCP antibody test-
ing. Although present in only 67% of the patients with RA, 
according to the meta-analysis carried out in 2005 by Visser,14 
a positive result is highly speci¿ c (> 96%) for the diagnosis 
of RA. It is currently considered the most speci¿ c marker for 
the diagnosis of RA, as recently reported by Zhao et al.15 Anti-
CCP antibodies and RF are not usually found in patients with 
AS.6 Our patient had high titers of RF and anti-CCP antibod-
ies associated with the arthritis of the hands, feet and elbows, 
indicating RA concomitant with AS, HLA-B27 positive, with 
inÀ ammatory low back pain and sacroiliitis. 
The classi¿ cation criteria for RA have been recently re-
viewed by the ACR and the EULAR.5 According to the new 
ACR/EULAR classi¿ cation (2010) for RA, patients have to 
add 6 points of some characteristics, considering that they 
have at least one synovitis not explained by another disease.
According to such classi¿ cation criteria for RA, our patient 
had the involvement of 2 large and 3 small joints, high titers of 
RF and anti-CCP antibodies, abnormal CRP and ESR levels, 
and symptoms for over 6 weeks. Considering all that, his total 
score was 8, and he could be classi¿ ed as having RA.
According to the modi¿ ed New York criteria for AS, our pa-
tient had bilateral sacroiliitis (grade 2, right side), characteristic 
inÀ ammatory low back pain, and reduced low back mobility 
and chest expandability. Furthermore, according to the ASAS 
classi¿ cation criteria for axial spondyloarthritis, our patient 
had his diagnosis con¿ rmed by being HLA-B27 positive and 
having sacroiliitis, in addition to inÀ ammatory low back pain 
and high CRP levels. 
Based on the criteria cited, our patient can be classi¿ ed as 
having both diseases: RA and AS. According to the literature, 
45 cases of the concomitance of both diseases have been 
reported.3 
Most of the previous reports have used clinical data and 
not all have assessed the presence of either HLA-B27 to sup-
port the hypothesis of AS or RF to support the hypothesis of 
RA (Table 1).  Toussirot et al.3 have reported a prevalence of 
6.6% of HLA B27-positive patients with RA and of 8.3% of 
RF-positive patients with AS versus a prevalence of 9.8% of 
controls, although the results had no statistical signi¿ cance. 
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Table 1
Review of the reports about patients with concomitant rheumatoid arthritis and ankylosing spondylitis
Reference First symptom(n of cases) Nodules PEA RF HLA-DR4 Anti-CCP
Low back 
pain Sacroiliitis Syndesmophytes HLA-B27
Rosenthal et al. Low back pain  (1) + ND + ND ND + + + ND
Rotés Querol 
et al. Low back pain (7) 2+ 3+ 7+ ND ND 7+ 7+ 2+ 7+
Luthra et al. Low back pain (2) 2+ 2+ 2+ ND ND 2+ 2+ 2+ 2+
Good et al. Low back pain  (3) 0+ 3+ 3+ ND ND 3+ 3+ 3+ 3+
Fallet et al.
Low back pain (5)
Polyarthritis (7)
Oligoarthritis (1)
Cervical pain (1)
Iritis (1)
6+ 14+ 15+ 7+ ND 11+ 15+ 11+ 15+
Clayman et al. Low back pain  (1) + + + ND ND + + + +
Espinoza et al. Low back pain  (1) + + + ND ND + + + +
Major et al.
Low back pain (2)
Low back pain  (1)
Polyarthritis (1)
ND (3)
1+; 5 ND 7+ 7+ 3+; 2 ND ND 2+; 5 ND 7+ 2+; 3 ND 5+
Lavery et al. Low back trauma (1) + + + ND ND + + + +
Alarcón-
Segovia et al. Low back pain  (1) + + + + ND + + + +
Sattar et al. Polyarthritis (1) − + + + ND + + + +
Helfgott et al. Low back pain (1) + + + + ND + + + +
Martinez et al. Oligoarthritis (1) − + + + ND + + + +
Toussirot et al. Polyarthritis (2)Cervical pain (1) 1+
2+; 
1 ND 2+ 0+ ND 3 + + 1+ 1+; 2 ND
Genc et al. Polyarthritis (1) − + − − ND + + + +
Our report Low back pain (1) − + + ND + + + + +
Total: 47 cases
Low back pain (18)
Low back pain  (8)
Polyarthritis (12)
Oligoarthritis (2)
Cervical pain (2)
Low back trauma (1)
Iritis (1)
ND (3)
21+ 40+ 45+ 10+ 1+ 38+ 45+ 31+ 42+
(+): presence of the item/symptom; (–): absence of the item/symptom; (ND):  presence/absence of the item not speciﬁ ed by the author; PEA:  peripheral erosive arthritis; RF: rheumatoid factor.
*For this review table, only articles published in English were considered.
This is the ﬁ rst case report using the last updates of the ACR/EULAR and the ASAS classiﬁ cation criteria for RA and AS, respectively, and anti-CCP antibody testing. We consider appropriate 
that future reports about the concomitance of RA and AS use anti-CCP testing in addition to the latest criteria for the diagnosis and classiﬁ cation of that rare association.
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Tabela 1
Revisão dos relatos publicados de pacientes com artrite reumatoide e espondilite anquilosante de ocorrência simultânea
Referência Primeiro sintoma(nº de casos) Nódulos AEP FR HLA-DR4 Anti-CCP Dor lombar Sacroiliíte Sindesmóﬁ tos HLA-B27
Rosenthal et al. Dor lombar baixa (1) + ND + ND ND + + + ND
Rotés Querol 
et al. Dor lombar (7) 2+ 3+ 7+ ND ND 7+ 7+ 2+ 7+
Luthra et al. Dor lombar (2) 2+ 2+ 2+ ND ND 2+ 2+ 2+ 2+
Good et al. Dor lombar baixa (3) 0+ 3+ 3+ ND ND 3+ 3+ 3+ 3+
Fallet et al.
Dor lombar (5)
Poliartrite (7)
Oligoartrite (1)
Dor cervical (1)
Irite (1)
6+ 14+ 15+ 7+ ND 11+ 15+ 11+ 15+
Clayman et al. Dor lombar baixa (1) + + + ND ND + + + +
Espinoza et al. Dor lombar baixa (1) + + + ND ND + + + +
Major et al.
Dor lombar (2)
Dor lombar baixa (1)
Poliartrite (1)
ND (3)
1+; 
5 ND 7+ 7+ 3+; 2 ND ND 2+; 5 ND 7+ 2+; 3 ND 5+
Lavery et al. Trauma lombar (1) + + + ND ND + + + +
Alarcón-
Segovia et al. Dor lombar baixa (1) + + + + ND + + + +
Sattar et al. Poliartrite (1) − + + + ND + + + +
Helfgott et al. Dor lombar (1) + + + + ND + + + +
Martinez et al. Oligoartrite (1) − + + + ND + + + +
Toussirot et al. Poliartrite (2)Dor cervical (1) 1+
2+; 
1 ND 2+ 0+ ND 3 + + 1+
1+; 
2 ND
Genc et al. Poliartrite (1) − + − − ND + + + +
Nosso relato Dor lombar (1) − + + ND + + + + +
Total: 47 casos
Dor lombar (18)
Dor lombar baixa (8)
Poliartrite (12)
Oligoartrite (2)
Dor cervical (2)
Trauma lombar (1)
Irite (1)
ND (3)
21+ 40+ 45+ 10+ 1+ 38+ 45+ 31+ 42+
(+): presença do item/sintoma; (–): ausência do item/sintoma ; (ND): presença/ausência do item não especiﬁ cado pelo autor; AEP: artrite erosiva periférica; FR: fator reumatoide.
*Para esta tabela de revisão, desconsideramos os artigos não publicados em língua inglesa.
Este é o primeiro relato de caso em que foram usadas as últimas atualizações dos critérios de classiﬁ cação do ACR/EULAR e grupo ASAS para AR e EA, e teste laboratorial para dosagem do anti-CCP. 
Consideramos adequado que futuros relatos de concomitância de AR e EA possam utilizar a dosagem do anti-CCP, além de critérios mais atualizados para o diagnóstico e classiﬁ cação desta rara ocorrência.
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